RxDoctor Payments Data

Sydney Masters, OD

Optometrist · Saint Joseph, MONPI 1386349470

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 21 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 8 manufacturers reported payments, led by Carl Zeiss Meditec, Inc. at 34.8% of the total. 2025 is the largest year on record at $306, 2.5 times the $121 reported in 2023. That places this record below the midpoint for optometrist clinicians in MO, where the typical reported total is $689.

$564in general payments, 2019–2025

Across 21 payments — averaging $26.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Carl Zeiss Meditec, Inc.$196
  • Bausch & Lomb Americas Inc.$109
  • Johnson & Johnson Vision Care, Inc.$82
  • Sun Pharmaceutical Industries Inc.$59
  • Oyster Point Pharma, Inc.$43
  • Harrow Eye, LLC$33
  • plus $42 from 2 others

What the payments were for

  • Food & beverage$564100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$564 in reported general payments places this provider in the 45th percentile of 1,030 optometrist providers in Missouri.

See all optometrist providers in Missouri →

Medicare billing

Part B allowed, 2024
$16,240
Medicare patients
128
Services billed
180

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ErythromycinErythromycin Base16$188

Paid to pharmacies, not to this prescriber.

Other optometrist in Saint Joseph

See the full list for Missouri →

Where these figures come from

Is this you, or does something look wrong? →